Prime Medicine, Inc. (PRME)
3.53
-0.18
(-4.85%)
USD |
NASDAQ |
Mar 18, 16:00
3.65
+0.12
(+3.40%)
After-Hours: 07:13
Prime Medicine Profit Margin (Quarterly) : -5.50K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -18.24% |
| Vanda Pharmaceuticals, Inc. | -246.8% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Lineage Cell Therapeutics, Inc. | 13.50% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -166.6% |
| Return on Assets | -47.91% |
| Return on Invested Capital | -89.81% |
| Gross Profit Margin (Quarterly) | -123.9% |
| Operating Margin (Quarterly) | -5.80K% |
| Return on Net Operating Assets | -149.9% |